Health Condition 1: null- Stress disorders characterized by Difficulty in concentration, Physical exhaustion, Anxiety, restlessness, insomnia, Headache, fatigue, loss of appetite, Phobia, Sweating, mental confusion.
Conditions
Interventions
Intervention1: Caplet containing Withania somnifera extract: One caplet once daily orally for 3 months
Control Intervention1: Placebo Caplet identical in shape and size to study drug: One Caplet once
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: Mild to moderate stress disorders characterized with Difficulty in concentration, Physical exhaustion, Anxiety, restlessness, insomnia, Headache, fatigue, loss of appetite, Phobia, Sweating, mental confusion etc. Age >18 years, both male and female subjects. Hematologic and Biochemical parameters within normal limits.
Exclusion criteria
Exclusion criteria: Patients with severe Psychiatric conditions. Pregnant & Breast feeding Women. Patients with severe Hepatic/ cardiac/ mental illness. History of Alcohol or smoking abuse. Patients unwilling to provide informed consent or abide by the requirements of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of Ashwagandha caplets in stress disorders in providing rapid symptomatic recoveryTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Ashwagandha caplets in stress disorders Provide rapid symptomatic recovery incidence of adverse events during the study period, and overall compliance to the drug treatmentTimepoint: 90 days | — |
Countries
India
Contacts
Public ContactDr Pralhad Patki
The Himalaya Drug Company
Outcome results
None listed